R&D Trends

Oncology Alliance, GNS launch initiative for colorectal cancer

Wednesday, December 16, 2015

The Alliance for Clinical Trials in Oncology, one of the five cooperative research groups in the U.S. sponsored by the National Cancer Institute conducting large multicenter trials in oncology, and GNS Healthcare (GNS), a precision medicine company that applies causal machine learning technology to match health interventions to individual patients and discover new target intervention pathways, have announced a big data initiative.

[Read More]

Bristol-Myers Squibb, UCLA enter immuno-oncology collaboration

Monday, December 14, 2015

Bristol-Myers Squibb has entered into a collaboration agreement with UCLA as part of Bristol-Myers Squibb’s Immuno-Oncology Rare Population Malignancy (I-O RPM) research program in the U.S. The I-O RPM research program is a multi-institutional initiative with academic-based cancer centers focused on the clinical investigation of immuno-oncology therapeutics as potential treatment options for patients with high risk, poor prognostic cancers, defined as a rare population malignancy.

[Read More]